Found 1,117 investors
George Heinrichs
United States
Mr. Richard Linder co-founded and also served as the President, Chief Executive Officer & Chairman of the Medical Advisory Board at CoNextions. He is an Angel Investor. He has twenty-three years of experience as an executive in various facets of the healthcare industry. Most recently, he served as Corporate Vice President for Remedy Informatics and as President of Heart & Vascular, overseeing strategy and positioning in that key vertical market. Mr. Linder began his career in the medical device industry in 1991 with Merit Medical Systems. In 1996, Rich co-founded Rubicon Medical, Inc. and served as President and Chief Executive Officer, taking the company public in 2000 and overseeing its acquisition by Boston Scientific in 2005. Following his tenure at Boston Scientific, where Rich served as Vice President of Vascular Protection, he served as President/CEO and a Director of Coherex Medical from 2006 to 2012. Coherex is a company dedicated to the minimally invasive treatment of structural heart disease. Mr. Linder also serves on the board of directors of Vital Access Corporation, a vascular access company. In addition to his leadership duties, Mr. Linder is very involved in the medical device and biotech community in Utah. Rich is a Co-Founder and Director of BIO-Utah, Utah's life science industry association, and currently serves as Chairman of the Board. He is a member of the University of Utah Biomedical Industrial Advisory Board and was voted a member of the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE). Rich is a member of the Volunteer Leadership Council for the College of Physical and Mathematical Sciences at Brigham Young University. Mr. Linder holds dozens of U.S. and international issued patents and pending patent applications for medical technologies in the areas and disease states coronary artery disease, peripheral vascular disease, neuro-interventional radiology, structural heart disease and heart failure. Mr. Linder attended both Brigham Young University and the University of Utah.
Individual/Angel
George Samenuk
United States
Mr. Robert Duggan is the Founder & serves as Chief Executive Officer at Duggan Investments (Florida). He serves as Board Member at Human Longevity. Mr. Duggan also serves as Chief Executive Officer at Summit. Mr. Duggan has been a member of the Board of Directors since September 2007 and was voted in as Chairman in September of 2008 after the resignation of its former Chairman. Since that time, Mr. Duggan has not received any compensation from the Company in any form, nor has he received any options for his services to the Company. In December 2008 and in March 2009, at a time when the Company had liquidity needs and required operating funds, Mr. Duggan provided loans to the Company totaling $6.4M. With the receipts of funds raised through a rights offering in July 2009, Mr. Duggan's loan was repaid. Alongside other Company stockholders and biotech investors, Mr. Duggan has invested since 2008 in each of the Company's capital raises, purchasing approximately his pro rata share in each raise, each of which were generally priced at market closes without any discounts. He purchased all his shares in Pharmacyclics outright and currently owns directly and indirectly approximately 20% of the outstanding shares. Disclosure regarding Mr. Duggan's stock ownership in the Company is publicly available in the Company's public SEC filings and in Mr. Duggan's filings on Schedule 13D, as amended, with the SEC. Mr. Duggan has also served as Chairman of the Board of Directors of Computer Motion, Inc., a computerized surgical systems company, from 1990 to 2003 and Chief Executive Officer from 1997. Computer Motion was acquired by Intuitive Surgical, Inc. in 2003. At that time Mr. Duggan became a Board Member of Intuitive Surgical, Inc. and served on its board until March 2011. Mr. Duggan has been an entrepreneur and industrialist for more than 30 years. He has participated as a CEO of, a director of, investor in and advisor to numerous small and large businesses in the medical equipment, computer local and wide area network, PC hardware and software distribution, digital encryption, consumer retail goods and outdoor media communication industry. Mr. Duggan has also assisted in corporate planning, capital formation and management for his various investments. In 1985 he received a Congressman's Medal of Merit from Congressman Ron Paul and in 2000 he was named a Knight of the Legion of Honor by President Jacques Chirac. Mr. Duggan is a member of the University of California at Santa Barbara Foundation Board of Trustees. He is also an Angel Investor.
Individual/Angel
Georgios Markakis
United States
Dr. Janice Gabrilove is an Angel Investor. She served as Scientific Advisor at Easton Capital Investment Group. She is board certified in Internal Medicine and Medical Oncology, is the Vice Chairman of Clinical Research at the Department of Medicine at the Mount Sinai Medical Center, New York, NY. She is a professor of Medical Oncology at Mount Sinai, Director of the Hematology/Oncology Fellowship Program, and Chairperson of the Clinical Care Committee. She is the Inventor of the American, Canadian, and European patent use of the recombinant human granulocyte colony stimulating factor in the treatment of mucositis, the coinventor of the American and Canadian patent human pluripotent granulocyte colony stimulating factor and the coinventor of the American, Canadian, and European application stimulation of bone marrow stromal and progenitor cells by human basic fibroblast growth factor. Dr. Gabrilove has served in an advisory capacity to a number of biotech companies and served for five years on the first FDA advisory board for the approval of biologics. She is on the Executive committee of the American Society of Hematology, and received her medical degree from the Mount Sinai School of Medicine.
Individual/Angel
Gerri Elliott
San Francisco, California, United States
Gerri Elliott has served as a member of our board of directors since August 2015. She currently serves on the boards of directors of lead...
Individual/Angel
Global Care Capital
Canada
Global Care Capital is a venture capital firm based in Toronto, Canada. The firm seeks to invest in the pharmaceuticals and biotechnology sectors.
Venture Capital
Global Fund (New York)
United States
Founded in 2015, Global Fund is a private equity firm based in New York, New York. The firm prefers to invest in mid to late-stage private companies and micro to small-cap public companies. The firm seeks to invest in the biotech, clean energy, fintech, and real estate sectors.
Private Equity Firm
Global IoT Technology Ventures, Inc.
Tokyo, Tokyo, Japan
GiTV is a venture capital investing into IoT technology businesses.
Venture Capital
Global Trust Ventures
United States
Global Trust Ventures was a private equity fund that preferred to invest in the biotech, security systems, specialty automotive, real estate and high-tech sectors. It was launched in 2003 and is based in Las Vegas, Nevada.
Private Equity Firm
GMS Capital Partners
United States
Founded in 2017, GMS Capital Partners is a private equity firm based in Washington, District of Columbia. The firm seeks to invest in software technology, consumer enterprise, pharmaceuticals, life sciences, biotechnology, telecommunications, real estate, energy, oil & gas, and agribusiness sectors.
Growth Capital
G.N. Tech Venture Capital
South Korea
G.N. Tech Venture Capital is the corporate venture capital arm of Kook Soon Dang Company and is based in South Korea. The firm seeks to invest in the healthcare and biotechnology sectors, with a focus on South Korea.
Venture Capital
Gobi-Hitech Investment
China
Founded in 2008, Gobi-Hitech Investment is an early and growth stage joint venture established in Tianjin by Tianjin Haitai Technology Investment Management and Gobi Partners. The firm seeks to make investments in sectors like TMT, biotechnology, information technology, new energy and renewable energy, nano and new materials, civil aviation technology industry, as well as key industries in the future Tianjin Binhai High-tech Zone.
Venture Capital
Gonzalo Utrilla
United States
Mr. Paul Intlekofer founded and served as Chief Executive Officer at MMG Fusion. He serves as President, Chief Financial Officer and Managing Partner at SFP Capital. Mr. Paul Intlekofer is the President of SFP Capital. Previously he was the Executive Vice President and Chief Marketing Officer of Medifast. As EVP, Chief Marketing Officer of Medifast, Inc. (NYSE: Med) Paul managed and directed the largest business units and led sales, marketing, and customer service driving revenue increases from $75MM to $275MM in three years. He turned around an underperforming Direct Response division and call center, creating improved profits from $4MM to $22MM and led the growth of its Direct Sales division from $40MM to $160MM. Medifast was ranked as the #1 Small Cap U.S. Company in 2010 by Forbes, two years after Paul joined the Company. In 2002 Paul joined Nutrition 21, a biotechnology company, to help it secure financing for R&D and to commercialize its technology. When the clinical trials failed, Paul was promoted to CEO, transformed the business and grew revenues from $10MM to $46MM in three years. The company was recognized by Nutrition Business Journal in 2006 for Acquisition of the Year, and in 2007 for Fastest Growing Small Cap Company.
Individual/Angel
Good Insight
China
Founded in 2009, Good Insight is an early and growth-stage venture capital firm based in Hubei, China. The firm seesk to make investments in sectors like Modern manufacturing, new materials, new energy, medical equipment, biotechnology, hospitals and chain medical institutions, emerging service industries, high-tech agriculture, branded consumer goods, and media.
Venture Capital
GP Healthcare Capital
Shanghai, Shanghai, China
GP Healthcare Capital is a venture capital that makes investments in companies based in the biotechnology industry.
Asset Management
Finance
Financial Services
Management Consulting
Private Equity Firm
Grace Harbor Capital
South Korea
Founded in 2003, NAU IB Capital is a private equity firm headquartered in Seoul, South Korea. The firm seeks to invest in companies operating in the pharmaceuticals, biotechnology, and life sciences sectors
Private Equity Firm
Graham Matthews
Canada
Mr. Graham Matthews is a Founder and serves as Principal at Upper Canada Ventures. He serves as Chief Financial Officer at iotum. He also is an Angel Investor. He is the Founder and serves as President and Chief Executive Officer at Upper Canada Ventures. He served as the Chief Financial Officer at Peraso Technologies. He has experience in financing small and medium-sized businesses. Previous to establishing Upper Canada Ventures, he was General Partner of VenGrowth Private Equity Partners, a large private equity investment firm. Prior to joining VenGrowth. He holds Bachelor of Commerce (Honours) and Master of Business Administration degrees from McMaster University.
Individual/Angel
Grant Investment Group
United States
Grant Investment Group was an investment management firm that managed equity options portfolios and healthcare funds of various sectors, such as biotechnology, pharmaceuticals, medical device, technology and internet. The firm was based in Overland Park, Kansas.
Private Equity Firm
Greater Phoenix Economic Council
United States
Greater Phoenix Economic Council is an accelerator based in Phoenix, Arizona. The firm runs a program for IoT technology-driven international firms seeking to expand to the United States of America.
Accelerator
Incubator
Green Innovations
Malta
Green Innovations is an venture capital firm based in Qormi, Malta. The firm seeks to invest in green technology, biotechnology, agriculture, housing, water, energy, telecom and education sectors.
Venture Capital
Grishin Robotics
Menlo Park, California, United States
Grishin Robotics is a VC firm, focused on robotics and IoT.
Angel Investment
Finance
Venture Capital
Venture Capital
Showing 481 to
500 of
1,117 results